Polycystic liver disease (PLD) associated with autosomal dominant polycystic kidney disease is usually well tolerated. However there is a small subset of patients who become incapacitated by massive liver enlargement and for whom effective nonsurgical therapy is limited. Recent surgical advances in the treatment of PLD have raised uncertainties regarding proper management of these highly symptomatic patients. We have reviewed our recent experience with a combined hepatic resection-fenestration procedure to assess its efficacy in nine patients. All patients underwent resection of two or more liver segments and extensive fenestration of residual cysts in the remnant liver. Symptomatic relief and reduction in abdominal girth were obtained in eight surviving patients, persisting for an average follow-up period of 17 months. No progression of cystic disease has been observed clinically or by computed tomography and hepatic function was preserved. Three patients had no complications. Five patients had complications including transient right pleural effusion (3) and thrombosis of an arteriovenous fistula (2) . One patient who had a previous hepatic cyst fenestration and a cadaveric renal transplantation died after operation of an intracerebral hemorrhage after experiencing coagulopathy, hyperbilirubinemia, and sepsis. Our results suggest (1) some highly symptomatic patients with massive PLD may benefit from combined hepatic resection and fenestration with acceptable risk, and (2) previous liver surgery and immunosuppressive therapy may increase the risk of such surgery. Longer follow-up is needed in a larger number of patients to determine the duration of benefit from the combined resection-fenestration procedure for highly symptomatic PLD. M W j r ULTIPLE HEPATIC CYSTS or polycystic liver disease (PLD) are frequently associated with autosomal dominant polycystic kidney disease (ADPKD). 1-5 During the past three decades, medical advances have increased the number of patients with ADPKD who survive long enough to develop severe liver involvement. As experience with such patients has increased, so too has the uncertainty over their proper management. Not infrequently symptomatic patients with PLD exhaust all conservative therapeutic options and From the Departments of Surgery,* Nephrology,t and Gastroenterology, f Mayo Clinic, Rochester, Minnesota surgery is considered the next alternative. Our purpose was to determine the value and consequences ofcombined hepatic resection and cyst fenestration for highly symptomatic patients with polycystic liver disease from our recent experience.
Patients and Methods
We reviewed the medical records of all patients with ADPKD who underwent radical resection for highly symptomatic PLD at the Mayo Clinic from 1985 to 1989. All patients were operated on by a single surgeon (DMN). Information abstracted from patient records included selection criteria, operative technique and extent of surgery, postoperative course, complications, and follow-up.
Patients were selected primarily on the basis of the severity of abdominal symptoms and impairment of clinical performance as estimated by the Performance Status Scale ofthe American Cancer Society Eastern Cooperative Oncology Group (ECOG). A score of 0 was assigned to unrestricted patients, 1 to patients restricted from strenuous physical activity, 2 to patients capable of self care, 3 to confined patients, and 4 to invalid patients.6 Additional indications for operation included infection of one or more hepatic cysts refractory to antibiotics and to percutaneous drainage, regardless of performance status. Hematology, coagulation and chemistry profiles, and nutritional assessment were obtained in each patient. Abdominal computed tomography (CT) scan was performed to delineate cyst distribution, to assess portal vein patency, and to serve as a baseline for follow-up comparison. In addition six patients had an exercise radionuclide cineangiography or a dipyridamole-thallium study to assess cardiovascular performance. Seven All patients underwent multisegmental hepatic resection. Two to six liver segments were excised in each patient (Table 3 ). An example of a massively enlarged polycystic liver with segmental sparing before and after resectionfenestration is shown in Figure 1 . The weights of the pathologic specimens ranged from 91 1 to 7600 grams and averaged 2869 grams. Because fluid was aspirated during cyst fenestration in each patient, the weight of the resected liver underestimated the net loss of mass in each patient. Weight loss during hospitalization ranged from 1.8 .0- '36 Nonsurgical treatment options for the few patients with incapacitating symptoms have been limited. Preliminary observations that hepatic cyst epthelia are sensitive to hormones that have an effect on the biliary system (e.g., secretin) suggest that the natural history of these cysts might be influenced pharmacologically.37 Whether reduction in extant cysts could be expected from hormonal therapy is unknown. Paliard et al. 38 found that cimetidine reduced the secretion rate of unroofed cysts, possibly by inhibiting gastric acidity and thus secretin-induced secretion. For patients who have only a few dominant cysts, percutaneous drainage has provided temporary relief.39 Subsequent sclerosis using 95% ethanol or pantopaque has reputedly prolonged the relief afforded by percutaneous drainage.442
Simple cyst fenestration and peritoneal marsupialization have been the mainstays of surgical therapy. Fenestration had produced incomplete or temporary pain relief but rarely documented reduction in abdominal girth. Lin et The long-term benefit of combined hepatic resection and fenestration will be determined by postoperative progression ofcystic degeneration in the spared liver remnant. Current data of the natural history of ADPKD and PLD suggest that progression of cystic disease will be slow, affording the possibility of prolonged benefit.'5 Although our follow-up is limited, clinical progression has not occurred in any of our patients. In contrast Iwatsuki and Starzl47 observed cystic progression in two patients, 8 and 9 years after partial hepatectomy. We fully agree that hepatic transplantation should be used for disabling symptoms from progression of PLD after resection. Primary hepatic transplantation for PLD should be used preferably in patients without liver sparing or in rare patients with liver failure.
